The Magnetic Mini-Mover Procedure (3MP) represents a novel approach to treating pectus excavatum, a prevalent congenital chest wall deformity. The market for pectus excavatum treatments is primarily composed of surgical interventions, which can be invasive and carry significant risks. This non-invasive alternative could appeal to parents and patients seeking less traumatic options. Given the limited competition in non-surgical treatments for this condition, successful outcomes could position UCSF as a leader in pediatric chest wall deformity corrections. However, the commercial viability will depend on the robustness of clinical data, regulatory pathways, and potential reimbursement strategies. Diligence should focus on the long-term efficacy and safety data, as well as the potential for broader applications of magnetic therapies in other deformities.